baber/WOPTO huggingface dataset:
Patent AU-2020200781-A1 (AU)
Title: Social Media platform, with rewards for posted content based on the influence of the content.
Inventor: HEATON PATRICK
IPC: G06Q20/06
Filed: 2020-02-04
Abstract: A system for rewarding social media users based on their posted content. The influence of posted 
content is measured from the reactions to the content, and users are rewarded based on the 
measured influence of their posted content. This may be achieved by the use of a distributed ledger
based smart contract.
Social Media platform*, with rewards for posted content 
based on the influence of the content.  
* Called "Touch" 
DRAWINGS 
Touch platform, social media app: T 
Provider of the Touch platform: Tc 
User who posts content: Uc 
User who views content: Uv 
User views the content: V 
Posting: P 
Posted content: C 
Reaction to the content after view: React 
Influence of the content: I 
Reward based on the reactions: Rew 
Smart Contracts: SC 
T 
Uc P -* C V Uv 
C Rew I React 
SC
Patent AU-2020201722-A1 (AU)
Title: Sous vide cooker
Inventor: MESSLER CARL HAKAN
IPC: A47J27/10
Filed: 2020-03-09
Abstract: A sous vide cooker having a housing, a bulkhead attached to the housing to form a 
first cavity, a heat sink attached to the bulkhead to form a second cavity, and a skirt 
attached to the bulkhead to form a third cavity below the heat sink. A TRIAC is physically 
attached in conductive thermal communication to the heat sink in the second cavity. The 
cooker also has a motor, an impeller located in the third cavity, a drive shaft extending 
through at least the heat sink and into the third cavity and operatively connecting the motor 
to the impeller, and a heating element located within the third cavity.  
19
1i7 
0 
CeC) 
N( 
0 
0 
0( 
(N 0r 
C~C) 
CD, 
N Nw 
(N 
C>N 
C) 0 c0
Patent AU-2020204352-A1 (AU)
Title: Method and system for point to point transaction processing
Inventor: MATTINGLY TIMOTHY WARREN
IPC: G06Q20/02
Filed: 2020-06-29
Abstract: OF THE DISCLOSURE 
A method for processing a point to point payment transaction includes: 
receiving a first transaction message related to a payment transaction including a 
transaction amount, primary account number, and recipient account number; 
5 generating a second transaction message related to the payment transaction including 
a payment amount based on the transaction amount; transmitting the second 
transaction message to a first financial institution associated with the primary account 
number; determining receipt of a currency amount equivalent to the payment amount 
from the first financial institution; generating a third transaction message related to 
10 the payment transaction including the recipient account number and a settlement 
amount based on the transaction amount; and transmitting the third transaction 
message to a second financial institution associated with the recipient account 
number.
Patent AU-2020213385-A1 (AU)
Title: Diagnostic tag for an industrial vehicle tag reader
Inventor: Steinbrunner Cole
IPC: G06K17/00
Filed: 2020-08-07
Abstract: CRO 0059 WO 
ABSTRACT OF THE DISCLOSURE 
An industrial vehicle comprising a tag reader, a reader module, and a diagnostic tag, 
wherein the diagnostic tag is coupled to the industrial truck within a read range of the tag 
reader. The reader module and the tag reader cooperate to identify the diagnostic tag and 
individual tags of a tag layout and the reader module discriminates between the individual 
tags of the tag layout and the diagnostic tag and the individual tags of the tag layout, 
correlates an identified individual tag of the tag layout with tag data, correlates an identified 
diagnostic tag with operation of the tag reader, and generates a missing tag signal if the 
diagnostic tag is not identified or the operation of the tag reader is not within specified 
operating parameters.
Patent AU-2020230333-A1 (AU)
Title: Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of TLR4 ligands and other biomarkers
Inventor: DE MIN CRISTINA
IPC: A61K39/395
Filed: 2020-09-11
Abstract: This invention relates generally to methods and compositions for diagnosing and 
treating disorders associated with elevated levels of Toll-like Receptor 4 (TLR4) ligands and 
other biomarkers. The invention also relates to methods of treating, delaying the progression 
of, or otherwise ameliorating a symptom of a disorder associated with elevated levels of 
TLR4 ligands and other biomarkers using agents that interfere with or otherwise antagonize 
TLR4 signaling, including neutralizing anti-TLR4 antibodies.
Patent AU-2020260273-A1 (AU)
Title: Concrete sensor device and system
Inventor: CATHCART ANDREW
IPC: G16Y20/10
Filed: 2020-04-14
Abstract: A concrete sensor device for use in monitoring physical properties within a body of concrete, the concrete sensor device being configured to be embedded inside the body of concrete in use, the concrete sensor device including: a sealed housing; sensors for measuring physical properties within the body of concrete, including: a temperature sensor; and a moisture sensor; a wireless transceiver for wirelessly communicating with a gateway device located outside of the body of concrete, the wireless transceiver being configured for wirelessly communicating at frequencies of less than 1 GHz; and a controller configured to: obtain sensor data from the sensors; generate monitoring data using at least some of the sensor data; and cause the monitoring data to be transmitted to the gateway device using the wireless transceiver, at predetermined intervals.
Patent AU-2020288422-A1 (AU)
Title: System and method for treating blepharitis using tissue stressing
Inventor: SHAVIT RONEN
IPC: A61B18/04
Filed: 2020-06-05
Abstract: Dermal conditioning device for creating at least one pressure point on at least an external surface of an eyelid, comprising at least one skin tissue lesion generator, at least one controller, a power supply and a housing, the controller coupled to the skin tissue lesion generator, a power supply coupled to the skin tissue lesion generator and the controller and the housing encasing the skin tissue lesion generator and the controller, wherein the controller controls the skin tissue lesion generator to generate at least one signal and to apply the signal to stress the external surface of an outer layer of the eyelid, the stress causing a formation of the pressure point on the eyelid without tissue coagulation, thereby activating at least one of a corneal reflex, a menace reflex and a lacrimation reflex of the eyelid by activating at least one nociceptor on the eyelid.
Patent AU-2020316003-A1 (AU)
Title: Coating composition for stain resistant coatings
Inventor: WANG MARIA
IPC: C09D133/14
Filed: 2020-07-24
Abstract: A coating composition includes: (a) a first acrylic polymer formed from a reaction mixture including: (i) an ethylenically unsaturated monomer including an acid group or an amine group; (ii) a reactive solvent reactive with the ethylenically unsaturated monomer (i); and (iii) a second monomer reactive with ethylenically unsaturated monomer (i); and (b) a second acrylic polymer different from the first acrylic polymer, where the second acrylic polymer (b) has a Mw of at least 100,000 Da. A method of preparing such a coating composition and coatings and coated substrates formed therefrom are also disclosed. Coatings formed from the disclosed coating composition may exhibit improved stain resistance.
Patent AU-2020326511-A1 (AU)
Title: Fusion proteins for improved enzyme expression
Inventor: OSBORN JUDILEE
IPC: C12P21/02
Filed: 2020-07-24
Abstract: Described herein are recombinant host organisms expressing a fusion protein with a foreign signal linked to the N-terminus of a mature polypeptide, such as an alpha-amylase, protease, beta-glucosidase or glucoamylase. Also described are processes for producing a fermentation product, such as ethanol, from starch or cellulosic-containing material with the recombinant host organisms.
Patent AU-2020356230-A1 (AU)
Title: A computer-implemented system and method for alerting an expectant mother to a medical risk during pregnancy
Inventor: LUI WING LAM
IPC: A61B5/00
Filed: 2020-09-18
Abstract: A computer-implemented system and method are for alerting an expectant mother to a medical risk during pregnancy. A profile of the expectant mother is used, and reports are received from the expectant mother identifying experienced symptoms. In response to a report at a particular time, any reports received over a subsequent time window are monitored, and based on the combination of reports received during the time window and the profile of the expectant mother, the need for a risk alert is determined. The user is more willing to report symptoms, because a risk alert (which functions as reporting symptoms to a medical expert) only takes place when a real risk is identified.
Patent AU-2020367800-A1 (AU)
Title: Security fence
Inventor: LUCZYCKI GEOFF T
IPC: E04H17/14
Filed: 2020-10-15
Abstract: A security fence includes a pair of posts and a plurality of rails supported by the pair of posts and disposed vertically spaced apart. Each rail includes a bottom wall and an upper wall, each defining a plurality of spaced apart openings. A plurality of pickets are horizontally spaced apart along the plurality of rails, each picket extends through a respective bottom opening and a respective upper opening of each rail. A slide lock bar is disposed within at least one of the plurality of rails and is supported by the bottom wall of the one of the plurality of rails. The slide lock bar traverses the plurality of pickets and is received by a notch in each picket. Engagement of the slide lock bar with the notches enables angular displacement of each picket with respect to each rail.
Patent AU-2020380895-A1 (AU)
Title: Feedback channel mapping and multiplexing HARQ reports in NR sidelink communication
Inventor: LIN HUEI-MING
IPC: H04W28/04
Filed: 2020-11-03
Abstract: The present invention relates to the field of feedback channel mapping and multiplexing HARQ reports in New Radio Sidelink (SL) communication. A method of operating a user equipment (UE) performing SL communication comprises providing a procedure to the UE, the procedure allowing the UE to determine a Physical Sidelink Feedback Channel (PSFCH) resource/sequence for Hybrid Automatic Repeat Request (HARQ) reporting with regard to the SL communication. The procedure provides instructions for a step-wise determination of the PSFCH resource/sequence for the HARQ reporting based on a first and second characteristic with regard to the SL communication.
Patent AU-2020383502-A1 (AU)
Title: Crystalline forms of a MAGL inhibitor
Inventor: GRICE CHERYL A
IPC: C07D263/32
Filed: 2020-11-12
Abstract: Described herein is new crystalline forms of the MAGL inhibitor 2-(2-((4-(((1,1,1,3,3,3-hexafluoropropan-2-yl)oxy)carbonyl)piperazin-1-yl)methyl)-5-(trifluoromethyl)phenoxy)-2-methylpropanoic acid, or a pharmaceutically acceptable salt thereof.
Patent WO-2021138711-A1 (WO)
Title: Float vessel for materials
Inventor: CARRINGTON ANN
IPC: F21V35/00
Filed: 2021-01-11
Abstract: A float vessel (10) comprises a buoyant body (12) which in one example has a decorative top portion (14) and a bottom portion (16) with a plurality of connection means (18) for material attachments (20). In use, the buoyant body (12) floats in a body of liquid, where the top portion (14) with the top surface (15) are above the liquid top surface, and the bottom portion (16) with the lower surface (17) are submerged in the liquid, being below the liquid top surface. The bottom portion (16) includes the plurality of connection means (18) disposed in a spaced manner along the lower surface (17). The connection means (18) provides a removable connection which allows a user to choose and customize the type of material attachments (32) connected to the body (12), as well as their specific arrangement on the lower surface (17). Each material attachment (20) in one example comprises a male threaded mount ring (30) with a material (32) permanently attached thereto. The material (32) as mentioned can be a crystal, a gemstone a mineral, or other natural material which is permanently attached to the mount ring (30).
Patent WO-2021222973-A1 (WO)
Title: Strap winder
Inventor: KHOURY EDWARD JOSEPH
IPC: B65H75/28
Filed: 2021-05-04
Abstract: A strap winder (10) comprising a body (12) having a spool (48) rotated by a motor (20). A slot (54) is provided in the spool (48) for receiving the end of a strap (11) to be wound. A guide arm (68) is provided having a first end pivotally mounted to the body (12) to rotate through a plane perpendicular to a longitudinal axis of the spool (48). The guide arm (68) has a strap guide (78) at a second end having a channel (80) for receiving a portion of the strap (11) such that the strap guide (78) guides the strap (11) onto the spool (48). The guide arm (68) also includes a spool guide (86) provided to engage with edges of the wound strap (11) to keep the strap (11) in a cylindrical configuration while winding.
Patent AU-2021200220-A1 (AU)
Title: Compounding device, system, kit, software, and method
Inventor: MUMPOWER MARIANO
IPC: A61J3/00
Filed: 2021-01-14
Abstract: An exemplary pharmaceutical compounding system and device for mixing materials from at 
least two distinct material sources can include a transfer set and junction structure that has a 
junction body, a first inlet port located at a first portion of the junction body, a second inlet port 
located at a second portion of the junction body, and an outlet port located at a third portion of 
the junction body. The junction structure can be configured to mix fluid received from both the 
first inlet port and second inlet port and to deliver the fluid to the outlet port. The junction 
structure can also include attachment structure located on the junction body and configured to 
attach the junction structure to the housing of the compounding device at a location downstream 
of a pump system.  
Figure 10 
47
15/35 
FIG. 10 
60e 2011 
6a 60e 2031 
63 
2021 60b 60c 60 
60f 
FIG. 11 
60 
65 62 
62 65 
65 
60f 62--" 
65 62 60a
Patent AU-2021202493-A1 (AU)
Title: A Vehicle Recovery Board
Inventor: NOMMENSEN DAVID
IPC: B60B39/12
Filed: 2021-04-23
Abstract: A vehicle recovery board comprising: 
an inner layer fabricated from a first material, the inner layer including a 
first face and an opposed second face, wherein the first face and the second face 
each comprise a plurality of inner layer projections extending outwardly therefrom; 
and 
an outer layer fabricated from a second material, the outer layer 
configured to substantially overlie the first face and the second face of the inner 
layer, wherein the outer layer comprises a plurality of outer layer projections 
extending outwardly therefrom, 
and wherein at least a portion of the plurality of outer layer projections are 
formed over at least a portion of the inner layer projections.
1/7 
DRAWINGS 
15 16 12 14 13 
10 
16 
11 
16 
12 FIG 1 
10 
18 
11 
FIG 2
Patent AU-2021220868-A1 (AU)
Title: Elevating walker chair and components
Inventor: BROWN GARRETT W
IPC: A47C3/30
Filed: 2021-02-11
Abstract: A foldable, elevating walker chair is disclosed having a height adjustment mechanism and a height limiter. The elevating walker chair has a unique lifting mechanism that allows the chair to be readily raised and lowered without motors. The weight of the elevating walker chair may be optimized by use of innovative bracing struts. The folding mechanism allows the elevating walker chair to achieve a compact configuration. Innovative components such as a swivel seat, hinges, seatbelt, telescoping wheel mounts, height adjustment devices and safety mechanisms may be included in the elevating walker chair.
Patent AU-2021224855-A1 (AU)
Title: SETD2 inhibitors and related methods and uses, including combination therapies
Inventor: RAIMONDI MARIA ALEJANDRA
IPC: A61K31/519
Filed: 2021-02-19
Abstract: The present disclosure provides SETD2 protein inhibitors, and methods, compositions, and kits for treating diseases, disorders, or conditions in a subject with a SETD2 protein inhibitor and, optionally, a second therapeutic agent, wherein the second therapeutic agent comprises one or more glucocorticoid receptor agonists, one or more immunomodulatory drugs, one or more proteasome inhibitors, one or more Bcl-2 inhibitors, one or more pleiotropic pathway modulators, one or more XPO1 inhibitors, one or more histone deacetylase inhibitors, or one or more EZH2 inhibitors, or a combination thereof.
Patent AU-2021230101-A1 (AU)
Title: Synergistic and targeting compositions for treatment of arterial and venous thrombosis
Inventor: CHEN RIDONG
IPC: A61K38/17
Filed: 2021-03-05
Abstract: Combinations of an apyrase and an annexin, including fusion proteins thereof, are synergistic antithrombotics that do not induce unwanted bleeding.
Patent AU-2021235152-A1 (AU)
Title: Detoxified lipopolysaccharides (IPS), naturally non-toxic lps, and uses thereof
Inventor: CAROFF MARTINE
IPC: A61K39/39
Filed: 2021-03-12
Abstract: The invention relates to an enriched population of modified lipopolysaccharide (LPS) molecular species being: - devoid of phosphate group at position C1 of the reducing end of their lipid A domain; and - substituted at position C6' of the non-reducing end of their lipid A domain by a hydrophilic moiety, with the proviso that said hydrophilic moiety is not a hydroxyl group. It also relates to compositions comprising the enriched population of modified LPS; and uses of naturally-occurring LPS molecular species and/or enriched population of modified LPS molecular species for treating and/or preventing cancer, inflammatory diseases or infectious diseases, and for stimulating an immune response or vaccinating a subject.
Patent AU-2021242353-A1 (AU)
Title: Artificial expression constructs for selectively modulating gene expression in non-neuronal brain cells
Inventor: TING JONATHAN
IPC: C12N15/67
Filed: 2021-03-26
Abstract: Artificial expression constructs for selectively modulating gene expression in selected central nervous system cell types are described. The artificial expression constructs can be used to selectively express synthetic genes or modify gene expression in astrocytes, oligodendrocytes, microglia, pericytes, SMC, or endothelial cells.
Patent AU-2021245220-A1 (AU)
Title: Pyrrolotriazine compounds as tam inhibitors
Inventor: LI YUN-LONG
IPC: A61P35/00
Filed: 2021-10-08
Abstract: This application relates to compounds of Formula I: 
H 
N CB 
NH 2  Cyc   N Cy 
O 
R -N / R2 
R3 N 
R1 
or pharmaceutically acceptable salts thereof, which are inhibitors of TAM kinases 
which are useful for the treatment of disorders such as cancer.
Patent AU-2021250947-A1 (AU)
Title: TDP-43-binding polypeptides useful for the treatment of neurodegenerative diseases
Inventor: JULIEN JEAN-PIERRE
IPC: C12N15/864
Filed: 2021-10-15
Abstract: Provided herein are antigen-binding constructs such as antibodies that bind to the RRM-1 
domain of TDP-43. The antigen-binding constructs are capable of blocking the interaction of 
TDP-43 with NF-KB in cells. Also provided herein are method of using the antigen-binding 
constructs in the treatment of diseases associated with TPD-43 proteinopathy, such as 
amyotrophic lateral sclerosis (ALS), frontotemperal lobar degeneration (FTLD), Lewy body 
disease and motor neuron disease.
Patent AU-2021269416-A1 (AU)
Title: Method and apparatus for filtering
Inventor: WIERZBA MICHAEL PAUL
IPC: A61M1/00
Filed: 2021-11-19
Abstract: Embodiments of the present disclosure provide a method and apparatus for filtering and 
surgical procedures. An exemplary apparatus includes an evacuation tube having a filter, a long axis 
and a hollow conduit extending through the long axis, the hollow conduit fluidly connecting a tube 
inlet and a tube outlet, the filter located within the hollow conduit operable to remove particles from 
a flow passing through the hollow conduit from the tube inlet to the tube outlet.  
15
Patent AU-2021276301-A1 (AU)
Title: Fused ring compounds, preparation method therefor, pharmaceutical compositions and use thereof
Inventor: DENG DAIGUO
IPC: C07D417/12
Filed: 2021-05-21
Abstract: The present invention relates to fused ring compounds, a preparation method therefor, pharmaceutical compositions and use thereof. The fused ring compounds have structural features of formula (I). The fused ring compounds are a type of somatostatin receptor subtype 4 (SSTR4) agonist compound having novel structures, better potency, high bioavailability and better solubility.
Patent AU-2021313426-A1 (AU)
Title: Nasal cannula
Inventor: POORMAND GHASSEM
IPC: A61M16/08
Filed: 2021-07-23
Abstract: A nasal cannula (1) configured to deliver airflow to a user, comprising: a manifold (2); a connector (8) for attaching a gas tube (7) to the manifold; a pair of non-sealing nasal prongs (3) extending from the manifold for delivering a supply of gas to a user via the gas tube; wherein the connector is configured to form a swivel connection with the manifold so as to provide relative rotation between the manifold and the gas tube.
Patent AU-2021314895-A1 (AU)
Title: Method for the bonding, transport, reaction activation, conversion, storage and release of water-soluble gases
Inventor: DIETZ ULRICH
IPC: B01D53/62
Filed: 2021-07-27
Abstract: The present invention relates to a method for the selective bonding, selective membrane transport and storage of carbon dioxide (CO2) in aqueous media. The method of the present invention comprises providing an aqueous acceptor solution which contains at least one acceptor compound which has a free guanidino group and/or amidino group which is brought into contact with a gas containing carbon dioxide in order to bond the carbon dioxide in the acceptor solution. The acceptor solutions obtained thereby, which contain bonded carbon dioxide, can be used for the storage of carbon dioxide in aqueous media, for the re-release of carbon dioxide, and for application in electrochemical methods, such as electrodialysis, in order to selectively transport bonded carbon dioxide through separation membranes in aqueous media. The present invention also relates to the preparation of carbonates starting from acceptor solutions which contain bonded carbon dioxide.
Patent AU-2021318515-A1 (AU)
Title: Immunoglobulin mediated vaccinations against viral diseases
Inventor: BLUTH MARTIN H
IPC: C07K16/00
Filed: 2021-07-26
Abstract: Techniques for inhibiting viral disease are provided. The techniques include obtaining a blood product from a convalescent patient, and administering the blood product to a patient at risk of contracting the same type of virus in order to propagate immunoglobulin-based vaccination.
Patent AU-2021320511-A1 (AU)
Title: Composition for treating KCA3.1 channel-mediated diseases comprising phenylalkyl carbamate compound
Inventor: KIM SEONG-JIN
IPC: A61P35/00
Filed: 2021-07-29
Abstract: The present invention relates to a composition for treating K
Patent AU-2021320634-A1 (AU)
Title: Comestible products
Inventor: DIMARTINO GIANLUCA
IPC: A21D2/36
Filed: 2021-08-02
Abstract: The invention provides cocoa pod husk powder having a concentration of insoluble dietary fibre of at least 55 wt.% of the total weight of the cocoa pod husk and/or having a concentration of total fibre of at least 68 wt.% of the total weight of the cocoa pod husk, and wherein the total ash content of the powder is no more than 6.0 wt.%. The invention further provides methods of making cocoa pod husk powders of the invention comprising the steps of: reducing cocoa pod husk in a wet-milling process to a paste; and drying the paste at a temperature of at least 80°C, or at least 85°C.
Patent AU-2021325428-A1 (AU)
Title: A process for preparation of clethodim
Inventor: PATEL RAKESH BHIKUBHAI
IPC: C07C319/20
Filed: 2021-08-11
Abstract: The present invention provides a process for the preparation of clethodim by reacting 5-[2-(ethylthio)propyl]-2-(1-oxopropyl)-1,3-cyclohexanedione with O-(3-chloro-2-propen-1-yl)hydroxylamine in the absence of a solvent. A continuous flow process for preparing clethodim is also provided.